Tue, May 16, 2023

Joseph Pantginis Reiterated (APRE) at Strong Buy and Held Target at $20 on, May 16th, 2023

Joseph Pantginis of HC Wainwright & Co., Reiterated "Aprea Therapeutics, Inc." (APRE) at Strong Buy and Held Target at $20 on, May 16th, 2023.

Joseph has made no other calls on APRE in the last 4 months.



There is 1 other peer that has a rating on APRE. Out of the 1 peers that are also analyzing APRE, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph


  • Jason McCarthy of "Maxim Group" Initiated at Strong Buy and Held Target at $16 on, Friday, March 10th, 2023